This proposal includes 10 funded Cores including: A) Administration, B) Development, which funded 17 NIAs since 1994, C) Biostatistics, which coordinates access to a UW HIV/AIDS biostatistics team; D) Clinical Research, funded several pilot grants leading to funded research and will collaborate with other cores to establish an HIV Specimen Repository Subcore; and will sponsor pilot grants for use of this repository and of Core G clinical data base; E) International Research, has coordinated research in over 50 developing countries over the past 5 years and will begin a new Subcore for HIV/AIDS Research in Women and Children; F) Clinical Retrovirology, expanded its BSL-3 space, introduced new technologies, and will initiate a new Molecular Pathology Virology Subcore; G) Health Services Research, supports longitudinal studies of problems in health care delivery and outcomes research; H) Genomics, a new core, will support genomics and bioinformatics research; I) Molecular Immunology - which developed methods for analyzing the cellular immune response to HIV, has introduced a BSL-3 flow cytometry/cell-sorting subcore; a tetramer assay subcore; and a humoral immunity subcore. Both Core H and Core I will add BIACORE facilities, for complementary, non duplicative uses; and J) SocioBehavioral and Prevention Research a new core, added due to increasing numbers of behavioral and prevention research expertise at the UW. Strategic planning for HIV/AIDS program development resulted in 180,000 sq. ft. of new or renovated space for CFAR members at the UW, including FHCRC and HMC, CHRMC, and SBRI. Ongoing strategic planning for the CFAR has been led by the Directors and the Executive Committee; guided by the new National CFAR Program Mission, and by our own CFAR theme emphasizing translational and interdisciplinary research; by assessment of strengths, needs, and opportunities represented by funded research programs and by perceptions of CFAR members; by recommendations from our External Advisory Committee, and by help from our Internal Advisory.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027757-19
Application #
7056793
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Program Officer
Namkung, Ann S
Project Start
1988-09-30
Project End
2008-02-29
Budget Start
2006-03-01
Budget End
2007-02-28
Support Year
19
Fiscal Year
2006
Total Cost
$3,213,108
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Wagner, Anjuli D; O?Malley, Gabrielle; Firdawsi, Olivia et al. (2018) Brief Report: Disclosure, Consent, Opportunity Costs, and Inaccurate Risk Assessment Deter Pediatric HIV Testing: A Mixed-Methods Study. J Acquir Immune Defic Syndr 77:393-399
Merlin, Jessica S; Long, Dustin; Becker, William C et al. (2018) Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes. J Acquir Immune Defic Syndr 79:77-82
LaCourse, Sylvia M; Cranmer, Lisa M; Njuguna, Irene N et al. (2018) Urine Tuberculosis Lipoarabinomannan Predicts Mortality in Hospitalized Human Immunodeficiency Virus-Infected Children. Clin Infect Dis 66:1798-1801
Golovaty, Ilya; Sharma, Monisha; Van Heerden, Alastair et al. (2018) Cost of Integrating Noncommunicable Disease Screening Into Home-Based HIV Testing and Counseling in South Africa. J Acquir Immune Defic Syndr 78:522-526
Torres, Thiago S; Harrison, Linda J; La Rosa, Alberto M et al. (2018) Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women. AIDS 32:583-593
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Patel, Rena C; Bukusi, Elizabeth A; Baeten, Jared M (2018) Current and future contraceptive options for women living with HIV. Expert Opin Pharmacother 19:1-12
Ross, Jennifer M; Ying, Roger; Celum, Connie L et al. (2018) Modeling HIV disease progression and transmission at population-level: The potential impact of modifying disease progression in HIV treatment programs. Epidemics 23:34-41
Wagner, Anjuli D; Shah, Seema K; Njuguna, Irene N et al. (2018) Financial Incentives to Motivate Pediatric HIV Testing-Assessing the Potential for Coercion, Inducement, and Voluntariness. J Acquir Immune Defic Syndr 78:e15-e18
Stekler, Joanne D; Milne, Ross; Payant, Rachel et al. (2018) Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort. PLoS Med 15:e1002537

Showing the most recent 10 out of 1275 publications